Advancements in Oncology: Breast Cancer

Advertisement
Nera Lopetegui-Lia, MDHER2 Breast Cancer | March 31, 2025
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Margaret Gatti-MaysTriple-Negative Breast Cancer | March 26, 2025
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Margaret Gatti-MaysHER2 Breast Cancer | March 31, 2025
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Rob DillardTriple-Negative Breast Cancer | March 25, 2025
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Rob DillardHER2 Breast Cancer | March 31, 2025
Dr. Margaret Gatti-Mays talks with The Oncology Brothers about the right treatments for endocrine-resistant breast cancer.
Rob DillardHR Breast Cancer | March 25, 2025
Dr. Margaret Gatti-Mays details the treatment options for BC patients in the hormone receptor-positive metastatic setting.
Rob DillardHR Breast Cancer | March 25, 2025
The Oncology Brothers spoke with Dr. Margaret Gatti-Mays, who provided invaluable insights on hormone receptor-positive BC.
Advertisement